Tuesday, November 28, 2017 9:09:04 AM
Penn are currently trialing CAR T in;
Lung Adenocarcinoma
Prostate
Ovarian Cancer
Multiple Myeloma
Peritoneal Carcinoma Pancreatic
Fallopian Tube Cancer
Non-Hodgkins Lymphoma (NHL)
Mesotheliomas
Pleural Malignant Melanoma
Breast Cancer
CD19+ Diffuse Large B-cell Lymphomas
Follicular Lymphomas
Mantle Cell Lymphomas
Mesothelioma Peritoneum
CART-PSMA-TGFßRDN Cells for Castrate-Resistant Prostate Cancer
University of Pennsylvania
HTTPS://clinicaltrials.gov/ct2/show/NCT03089203?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=1&rank=4
CART-BCMA Cells for Multiple Myeloma
HTTPS://clinicaltrials.gov/ct2/show/NCT02546167?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=2&rank=10
CAR T Cell Immunotherapy for Pancreatic Cancer
HTTPS://clinicaltrials.gov/ct2/show/NCT03323944?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=1&rank=13
CAR T Cells in Mesothelin Expressing Cancers
HTTPS://clinicaltrials.gov/ct2/show/NCT03054298?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=1&rank=16
Non-Hodgkins Lymphoma (NHL)
HTTPS://clinicaltrials.gov/ct2/show/NCT02030834?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=1&rank=14
Malignant Melanoma
Breast Cancer
HTTPS://clinicaltrials.gov/ct2/show/NCT03060356?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=1&rank=22
CD19+ Diffuse Large B-cell Lymphomas
Follicular Lymphomas
Mantle Cell Lymphomas
HTTPS://clinicaltrials.gov/ct2/show/NCT02650999?term=car+t&lead=University+of+Pennsylvania&spons=University+of+Pennsylvania&cntry1=NA%3AUS&cntry2=EU%3AGB&phase=0124&draw=1&rank=27
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM